Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Novel Therapeutic Advances to Improve Outcomes in Patients with Tenosynovial Giant Cell Tumor

Program Overview

This continuing medical education series includes three, 30-minute serialized, educational interviews, designed to bring clinicians up to date on novel therapeutic advances to improve outcomes in patients with tenosynovial giant cell tumor (TGCT). Tenosynovial giant cell tumor is a rare tumor that often leads to severe morbidity or functional limitations. TGCT is categorized into two subtypes, localized and ...
View Course
Managing Hemorrhagic Complications and Bleeding Risks Associated with Platelet P2Y12 Inhibitor Therapy

Program Overview

Antiplatelet therapy is an essential part of secondary prevention of cardiovascular events.  In particular, dual antiplatelet therapy (DAPT) — the combination of aspirin with an oral P2Y12 receptor antagonist — is the predominant approach in patients with acute coronary syndromes (ACS), coronary-artery stenting, or previous myocardial infarction (MI). The three oral P2Y12 receptor antagonists that are in use ...
View Course
Therapeutic Advances for the Management of Pediatric Patients with Atopic Dermatitis

Program Overview

This continuing medical education program is derived from material presented in an AcademicCME-sponsored symposium held in conjunction with the 2020 AAP Virtual National Conference & Exhibition. This continuing medical education program will highlight therapeutic advances for the management of patients with atopic dermatitis, focusing primarily on the pediatric population. The expert faculty, chaired by Dr. Lawrence F. Eichenfield, ...
View Course
The Science and Guidelines Concerning COVID-19 and Biosimilar Therapeutics for Inflammatory Conditions

Program Overview

In this module, Rowena Schwartz PharmD, BCOP, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair, will provide current data for treating patients with biosimilars in the era of the COVID-19 pandemic. The expert faculty will highlight the evolving impact of COVID-19 on healthcare expenditure, including availability of services and financial burdens. Therapeutic considerations amidst the pandemic ...
View Course
Incorporating Biosimilars into Treatment Plans for Inflammatory Rheumatological Disorders

Program Overview

In this module, Jonathan Kay, MD, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair and Francis A. Farraye, MD, MSc, will review current clinical trial data, including registry data, of biosimilar therapeutics in patients with rheumatological disorders. The expert faculty will analyze recent studies, debating the clinical implications of each. Terms such as biosimilarity, changing and ...
View Course
Incorporating Biosimilars into Treatment Plans for Inflammatory Gastroenterological Disorders

Program Overview

In this module, Francis A. Farraye, MD, MSc, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair and Jonathan Kay, MD, will analyze current clinical trial of data of biosimilar agents, particularly in gastroenterological disorders. Efficacy and immunogenicity in both induction and switching studies will be reviewed, and clinical relevance debated. The expert faculty will also relay ...
View Course
Loading...

Upcoming Events

Maui Derm for the Dermatologist 2021

January 25th – 29th, 2021

Advanced Curriculum for Multiple Sclerosis 2021

February 23rd – 24th, 2021

ACTRIMS Forum 2021

February 25th – 27th, 2021

CCR East Annual Meeting

August 12th-15th, 2021